NCT00292526View on ClinicalTrials.gov

Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
CardiotoxicityChemotherapeutic Toxicity
Interventions
DRUG

Enalapril

enalapril orally administered

Trial Locations (1)

20141

European Institute of Oncology, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER

NCT00292526 - Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients | Biotech Hunter | Biotech Hunter